Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline on Cognition in Parkinson's Disease
NCT01382342Phase 4Completed
- Sponsor
- Brown University
- Start
- Jun 2011
- Primary completion
- Feb 2014
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Rasagiline with Placebo (2 arms). Primary endpoint: Rey Auditory Verbal Learning Test at 6 months. Started Jun 2011; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01382342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382342.